<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Aggressive B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> are diverse group of <z:hpo ids='HP_0002664'>neoplasms</z:hpo> that arise at different stages of B-cell development and by various mechanisms of <z:e sem="disease" ids="C0007621" disease_type="Neoplastic Process" abbrv="">neoplastic transformation</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The aggressive B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> include many types, subtypes and variants of diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>), Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>), mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and its blastoid variant, and B lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Differences in histology, cytogenetic and molecular abnormalities, as well as the relationship with the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> microenvironment, help define characteristic signatures for these <z:hpo ids='HP_0002664'>neoplasms</z:hpo>, and in turn dictate potential therapeutic targets </plain></SENT>
<SENT sid="3" pm="."><plain>Rather than survey the entire spectrum of aggressive B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, this report aims to identify and characterize important clinically aggressive subtypes of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, and explore the relationship of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and the gray zone between them (B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> unclassifiable with features intermediate between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) </plain></SENT>
</text></document>